Form D · Biotechnology
EXUMA Biotech Corp.
West Palm Beach, FL · CIK 0001698021
Offering snapshot reported Aug 20, 2026 · SEC filing
- Reported sold
- $70M Offering amount: $70M
- Investors reported
- 26 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 26, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 20, 2026 | Initial | $70,000,000 | No comparison | 26 | SEC filing |
| Apr 21, 2020 | Initial | $18,950,000 | No comparison | 12 | SEC filing |
| Feb 23, 2017 | Initial | $44,000,007 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594882
Source: Form D, filed Aug 20, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Daniel Flynn | Director |
| Gregory Frost | Director, Executive |
| Houston Holmes | Director |
| Frank Mc Cormick | Director |
| David Ramsay | Director |
| Scott Segal | Director |
| Jay Short | Director |
| Richard Yan | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
625 N. Flagler Drive Suite 625
West Palm Beach, FL, 33401
Phone: 858-200-5193
West Palm Beach, FL, 33401
Phone: 858-200-5193